General Info

Unigene Laboratories is a biopharmaceutical company engaged in the research, production and delivery of small proteins, referred to as peptides, which have demonstrated or may have potential medical benefits. The company has developed a patented manufacturing technology for producing many peptides cost-effectively. It has patented oral and nasal delivery technologies that have been shown to deliver medically useful amounts of various peptides into the bloodstream. Unigene s primary focus has been on the development of calcitonin and other peptide products for the treatment of osteoporosis and other indications. Unigene has licensed worldwide rights to its manufacturing and delivery technologies for oral parathyroid hormone, referred to as PTH, to GlaxoSmithKline. The company received approval from the United States Food and Drug Administration for its nasal calcitonin product, trademarked Fortical. Unigene Laboratories is headquartered in Fairfield, N.J.